Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress

Molecular and Cellular Biology

Volumn 33, Issue 12, 2013, Pages 2425-2435

  Ham, Mira ^a   Lee, Joo Won ^a   Choi, A Hyun ^a   Jang, Hagoon ^a   Choi, Goun ^a   Park, Jiyoung ^a   Kozuka, Chisayo ^b   Sears, Dorothy D ^c   Masuzaki, Hiroaki ^b   Kima, Jae Bum ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; INSULIN SENSITIVITY; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL LINE; CHEMOKINE CCL2; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GREEN FLUORESCENT PROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NADP; NF-KAPPA B; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 84878983557     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01260-12     Document Type: Article

References (60)

1. Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:846-840.
2. Lumeng CN, Saltiel AR. 2011. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121:2111-2117.
3. Shoelson SE, Lee J, Goldfine AB. 2006. Inflammation and insulin resistance. J. Clin. Invest. 116:1793-1801.
4. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91.
5. Ito A, Suganami T, Yamauchi A, Degawa-Yamauchi M, Tanaka M, Kouyama R, Kobayashi Y, Nitta N, Yasuda K, Hirata Y, Kuziel WA, Takeya M, Kanegasaki S, Kamei Y, Ogawa Y. 2008. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J. Biol. Chem. 283:35715-35723.
6. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116:1494 -1505.
7. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, Jr. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116:115-124.
8. Olefsky JM, Glass CK. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72:219 -246.
9. Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. 2009. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458:1180 - 1184.
10. Gwinn MR, Vallyathan V. 2006. Respiratory burst: role in signal transduction in alveolar macrophages. J. Toxicol. Environ. Health B Crit. Rev. 9:27-39.
11. Fialkow L, Wang Y, Downey GP. 2007. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 42:153-164.
12. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258.
13. Lo YY, Cruz TF. 1995. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 270:11727-11730.
14. Forman HJ, Torres M. 2001. Redox signaling in macrophages. Mol. Aspects Med. 22:189 -216.
15. Emre Y, Nubel T. 2010. Uncoupling protein UCP2: when mitochondrial activity meets immunity. FEBS Lett. 584:1437-1442.
16. Lambeth JD. 2004.NOXenzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181-189.
17. Park J, Rho HK, Kim KH, Choe SS, Lee YS, Kim JB. 2005. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol. Cell. Biol. 25:5146 -5157.
18. Lee JW, Choi AH, Ham M, Kim JW, Choe SS, Park J, Lee GY, Yoon KH, Kim JB. 2011. G6PD up-regulation promotes pancreatic beta-cell dysfunction. Endocrinology 152:793- 803.
19. Park J, Choe SS, Choi AH, Kim KH, Yoon MJ, Suganami T, Ogawa Y, Kim JB. 2006. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes 55: 2939-2949.
20. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chiu DT. 1998. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett. 436:411- 414.
21. Kim KH, Yoon JM, Choi AH, Kim WS, Lee GY, Kim JB. 2009. Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. Mol. Endocrinol. 23:466-474.
22. Salati LM, Amir-Ahmady B. 2001. Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu. Rev. Nutr. 21:121-140.
23. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95:2409 -2415.
24. Suganami T, Nishida J, Ogawa Y. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25:2062-2068.
25. Han CY, Umemoto T, Omer M, Den Hartigh LJ, Chiba T, LeBoeuf R, Buller CL, Sweet IR, Pennathur S, Abel ED, Chait A. 2012. NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes. J. Biol. Chem. 287: 10379-10393.
26. Kamata H, Hirata H. 1999. Redox regulation of cellular signalling. Cell Signal. 11:1-14.
27. Torres M, Forman HJ. 2003. Redox signaling and the MAP kinase pathways. Biofactors 17:287-296.
28. Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, Man Y, Wang S, Yang J, Li J. 2010. The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J. Biol. Chem. 285:29965-29973.
29. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. 1996. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:4138-4142.
30. Ishiyama J, Taguchi R, Yamamoto A, Murakami K. 2010. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells. Atherosclerosis 209: 118-124.
31. Wang X, Martindale JL, Liu Y, Holbrook NJ. 1998. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333:291-300.
32. Yuan H, Zhang X, Huang X, Lu Y, Tang W, Man Y, Wang S, Xi J., Li J. 2010. NADPH oxidase 2-derived reactive oxygen species mediate FFAsinduced dysfunction and apoptosis of beta-cells via JNK, p38 MAPK and p53 pathways. PLoS One 5:e15726. doi:10.1371/journal.pone.0015726.
33. Haschemi A, Kosma P, Gille L, Evans CR, Burant CF, Starkl P, Knapp B, Haas R, Schmid JA, Jandl C, Amir S, Lubec G, Park J, Esterbauer H, Bilban M, Brizuela L, Pospisilik JA, Otterbein LE, Wagner O. 2012. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 15:813- 826.
34. Cosentino C, Grieco D, Costanzo V. 2011. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 30:546 -555.
35. Leopold JA, Zhang YY, Scribner AW, Stanton RC, Loscalzo J. 2003. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler. Thromb. Vasc. Biol. 23:411- 417.
36. Gaetani GD, Parker JC, Kirkman HN. 1974. Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U. S. A. 71:3584 -3587.
37. Frank JE. 2005. Diagnosis and management of G6PD deficiency. Am. Fam Physician 72:1277-1282.
38. Guo L, Zhang Z, Green K, Stanton RC. 2002. Suppression of interleukin- 1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry 41:14726 -14733.
39. Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang YY, Loscalzo AJ, Stanton RC, Loscalzo J. 2003. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J. Biol. Chem. 278:32100 -32106.
40. Hothersall JS, Gordge M, Noronha-Dutra AA. 1998. Inhibition of NADPH supply by 6-aminonicotinamide: effect on glutathione, nitric oxide and superoxide in J774 cells. FEBS Lett. 434:97-100.
41. Gupte SA, Arshad M, Viola S, Kaminski PM, Ungvari Z, Rabbani G, Koller A, Wolin MS. 2003. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 285:H2316-H2326.
42. Wilmanski J, Siddiqi M, Deitch EA, Spolarics Z. 2005. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6- phosphate dehydrogenase-deficient mouse peritoneal macrophages. J. Leukoc. Biol. 78:85-94.
43. Sanna F, Bonatesta RR, Frongia B, Uda S, Banni S, Melis MP, Collu M, Madeddu C, Serpe R, Puddu S, Porcu G, Dessi S, Batetta B. 2007. Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects. J. Vasc. Res. 44:253-263.
44. Roos D, van Zwieten R, Wijnen JT, Gomez-Gallego F, de Boer M, Stevens D, Pronk-Admiraal CJ, de Rijk T, van Noorden CJ, Weening RS, Vulliamy TJ, Ploem JE, Mason PJ, Bautista JM, Khan PM, Beutler E. 1999. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 94:2955-2962.
45. van Bruggen R, Bautista JM, Petropoulou T, de Boer M, van Zwieten R, Gomez-Gallego F, Belohradsky BH, Hartwig NG, Stevens D, Mason PJ, Roos D. 2002. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100:1026 -1030.
46. Cooper MR, DeChatelet LR, McCall CE, LaVia MF, Spurr CL, Baehner RL. 1972. Complete deficiency of leukocyte glucose-6- phosphate dehydrogenase with defective bactericidal activity. J. Clin. Invest. 51:769 -778.
47. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. 2001. Antioxidants inhibit JNK and p38MAPKactivation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens. Res. 24: 251-261.
48. Sekharam M, Cunnick JM, Wu J. 2000. Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. Biochem. J. 346:751-758.
49. Baker RG, Hayden MS, Ghosh S. 2011. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 13:11-22.
50. Nowak DE, Tian B, Jamaluddin M, Boldogh I, Vergara LA, Choudhary S, Brasier AR. 2008. RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol. Cell. Biol. 28: 3623-3638.
51. Kamata H, Manabe T, Oka S, Kamata K, Hirata H. 2002. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 519:231-237.
52. Hui X, Li H, Zhou Z, Lam KS, Xiao Y, Wu D, Ding K, Wang Y, Vanhoutte PM, Xu A. 2010. Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J. Biol. Chem. 285:10273-10280.
53. Nishi K, Oda T, Takabuchi S, Oda S, Fukuda K, Adachi T, Semenza GL, Shingu K, Hirota K. 2008. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen speciesdependent manner. Antioxid. Redox Signal. 10:983-995.
54. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1914 -1923.
55. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, Glembotski CC. 2000. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J. Biol. Chem. 275:23814 -23824.
56. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J., Chen ZJ. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346 -351.
57. Zechner D, Craig R, Hanford DS, McDonough PM, Sabbadini RA, Glembotski CC. 1998. MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273:8232- 8239.
58. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. 2003. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91:7A-11A.
59. Begriche K, Igoudjil A, Pessayre D, Fromenty B. 2006. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6:1-28.
60. Khaper N, Bryan S, Dhingra S, Singal R, Bajaj A, Pathak CM, Singal PK. 2010. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid. Redox Signal. 13:1033-1049.